We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Retinal Organoids as an Emerging Tool for Drug Discovery

Retinal Organoids as an Emerging Tool for Drug Discovery content piece image

Human induced pluripotent stem cell (iPSC)-derived retinal organoids are an emerging tool for the study of retinal development, disease modeling and drug discovery. In this webinar, we will focus on exploring the characteristics and utility of these organoids. In particular, their applications in gene therapy and toxicology will be discussed with examples of successful case studies.

Attend this webinar to:

  • Learn about the characteristics of iPSC-derived retinal organoids
  • Get an understanding of various applications of the retinal organoid technology
  • Learn about Newcells Biotech offerings for ocular in vitro models
Dr Valeria Chichagova
Dr Valeria Chichagova
Associate Director, Head of iPSC Technology, Newcells Biotech